IMV-seminar, SIMRAN MAGGO, Understanding Drug Reactions Using Genome Sequencing (UDRUGS) study: A New Zealand initiative to investigate the genetics of adverse drug reactions.
- Datum: 05 juni, kl. 12.00–13.00
- Plats: Akademiska sjukhuset Hedstrandsalen, Ing 70, bv
- Föreläsare: Simran Maggo
- Kontaktperson: Katarina Jonasson Vangen
Understanding Drug Reactions Using Genome Sequencing (UDRUGS) study:
A New Zealand initiative to investigate the genetics of adverse drug reactions (ADRs).
Simran Maggo | Carney Centre research fellow
GENE STRUCTURE AND FUNCTION LABORATORY
Carney centre for pharmacogenomics
DEPARTMENT OF PATHOLOGY AND BIOMEDICAL SCIENCE
UNIVERSITY OF OTAGO, CHRISTCHURCH, NEW ZEALAND
Simran Maggo has a strong interest in drug-induced adverse drug reactions (ADRs) and is currently investigating the genetic basis of common and rare ADRs. Maggo has a background in Pharmacology and has completed his undergraduate (BSc) and post-graduate (MSc) study at the Department of Pharmacology, University of Otago, Dunedin, New Zealand. During his PhD, Maggo investigated a controversial ADR - Statin-induced deficits in memory. Maggo investigated this ADR in an animal model by utilising behavioural and electrophysiological techniques.
Currently, Maggo works as a Research Fellow in Dept. of Pathology & Biomedical Science at University of Otago, Christchurch Campus. He Maggo is part of the Gene Structure and Function Laboratory and the main research interest of the research group lies in uncovering genetic reasons for both disease and Adverse Drug Reactions. Maggo is currently working on four main projects, which he will describe briefly today.
Host: Mia Wadelius